Friday, March 29, 2019 2:16:30 PM
I DONT THINK THE FDA WOULD'VE EVEN TRIED TO BRING IT UP IF THEY SAW WHO WAS REPRESENTING BIEL.
This is NOT a knock on the BIEL team, it just proves what lengths the FDA will go to continue to protect big pharma.
We need THE BEST REPRESENTATION to get the full approval.
Even if they get approved for women, they will still have to continue their dialogue with the FDA to get it cleared for Men. Thats still gonna cost more money, which could've been circumvented if better ADULT decisions were made [LAST YEAR]!
My comments above are simply my opinion and nothing more.
I'm enthusiastic at times however I am NOT a professional trader.
Please contact a financial consultant for investment advice.
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM